CSS
TRDA icon

Cubist Systematic Strategies’s Entrada Therapeutics TRDA Stock Holding History

Cubist Systematic Strategies’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$712K Buy
+122,676
New +$718K ﹤0.01% 2112
2023
Q2 		– Sell
-4,160
Closed -$60.3K – 4304
2023
Q1 		$60.3K Buy
4,160
+3,755
+927% +$50.1K ﹤0.01% 3535
2022
Q4 		$5.48K Sell
405
-600
-60% -$10.5K ﹤0.01% 4086
2022
Q3 		$16K Sell
1,005
-869
-46% -$11K ﹤0.01% 4252
2022
Q2 		$23K Buy
+1,874
New +$14.2K ﹤0.01% 4197
2022
Q1 		– Sell
-11,090
Closed -$190K – 3776
2021
Q4 		$190K Buy
+11,090
New +$269K ﹤0.01% 3049

Other funds holding TRDA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return